Pediatrix Medical Group Total Assets Growth & History (MD)
Pediatrix Medical Group's total assets was $2.25B for fiscal 2025.
View full Pediatrix Medical Group company overviewPediatrix Medical Group annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $2.25B | $94.0M | +4.37% |
| 2024 | 2024-12-31 | $2.15B | −$67.1M | −3.02% |
| 2023 | 2023-12-31 | $2.22B | −$128.1M | −5.45% |
| 2022 | 2022-12-31 | $2.35B | −$374.7M | −13.76% |
| 2021 | 2021-12-31 | $2.72B | −$625.4M | −18.68% |
| 2020 | 2020-12-31 | $3.35B | −$798.0M | −19.25% |
| 2019 | 2019-12-31 | $4.15B | −$1.79B | −30.17% |
| 2018 | 2018-12-31 | $5.94B | $70.2M | +1.20% |
| 2017 | 2017-12-31 | $5.87B | $527.9M | +9.89% |
| 2016 | 2016-12-31 | $5.34B | $792.2M | +17.42% |
| 2015 | 2015-12-31 | $4.55B | $939.0M | +26.02% |
| 2014 | 2014-12-31 | $3.61B | $599.5M | +19.93% |
| 2013 | 2013-12-31 | $3.01B | $258.4M | +9.39% |
| 2012 | 2012-12-31 | $2.75B | $477.7M | +21.02% |
| 2011 | 2011-12-31 | $2.27B | $235.0M | +11.53% |
| 2010 | 2010-12-31 | $2.04B | $348.3M | +20.62% |
| 2009 | 2009-12-31 | $1.69B | — | — |
Pediatrix Medical Group quarterly total assets
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.13B | $28.2M | +1.34% |
| Q1 2026 | 2026-03-31 | $2.07B | $76.8M | +3.85% |
| Q4 2025 | 2025-12-31 | $2.25B | $94.0M | +4.37% |
| Q3 2025 | 2025-09-30 | $2.20B | $122.5M | +5.90% |
| Q2 2025 | 2025-06-30 | $2.10B | $106.7M | +5.35% |
| Q1 2025 | 2025-03-31 | $1.99B | −$174.7M | −8.06% |
| Q4 2024 | 2024-12-31 | $2.15B | −$67.1M | −3.02% |
| Q3 2024 | 2024-09-30 | $2.08B | −$249.5M | −10.72% |
| Q2 2024 | 2024-06-30 | $2.00B | −$310.2M | −13.45% |
| Q1 2024 | 2024-03-31 | $2.17B | −$151.9M | −6.55% |
| Q4 2023 | 2023-12-31 | $2.22B | −$128.1M | −5.45% |
| Q3 2023 | 2023-09-30 | $2.33B | −$5.6M | −0.24% |
| Q2 2023 | 2023-06-30 | $2.31B | −$64.1M | −2.71% |
| Q1 2023 | 2023-03-31 | $2.32B | −$20.9M | −0.89% |
| Q4 2022 | 2022-12-31 | $2.35B | −$374.7M | −13.76% |
| Q3 2022 | 2022-09-30 | $2.33B | −$314.1M | −11.87% |
| Q2 2022 | 2022-06-30 | $2.37B | −$185.5M | −7.26% |
| Q1 2022 | 2022-03-31 | $2.34B | −$142.8M | −5.75% |
| Q4 2021 | 2021-12-31 | $2.72B | −$625.4M | −18.68% |
| Q3 2021 | 2021-09-30 | $2.65B | −$778.7M | −22.74% |
| Q2 2021 | 2021-06-30 | $2.56B | −$832.1M | −24.57% |
| Q1 2021 | 2021-03-31 | $2.48B | −$1.84B | −42.50% |
| Q4 2020 | 2020-12-31 | $3.35B | −$798.0M | −19.25% |
| Q3 2020 | 2020-09-30 | $3.42B | −$865.8M | −20.18% |
| Q2 2020 | 2020-06-30 | $3.39B | −$2.25B | −39.93% |
| Q1 2020 | 2020-03-31 | $4.32B | −$1.39B | −24.30% |
| Q4 2019 | 2019-12-31 | $4.15B | −$1.79B | −30.17% |
| Q3 2019 | 2019-09-30 | $4.29B | −$1.55B | −26.51% |
| Q2 2019 | 2019-06-30 | $5.64B | −$220.8M | −3.77% |
| Q1 2019 | 2019-03-31 | $5.71B | −$176.8M | −3.01% |
| Q4 2018 | 2018-12-31 | $5.94B | $70.2M | +1.20% |
| Q3 2018 | 2018-09-30 | $5.84B | $158.2M | +2.78% |
| Q2 2018 | 2018-06-30 | $5.86B | $452.2M | +8.36% |
| Q1 2018 | 2018-03-31 | $5.88B | $458.2M | +8.45% |
| Q4 2017 | 2017-12-31 | $5.87B | $527.9M | +9.89% |
| Q3 2017 | 2017-09-30 | $5.68B | $336.7M | +6.30% |
| Q2 2017 | 2017-06-30 | $5.41B | $636.0M | +13.33% |
| Q1 2017 | 2017-03-31 | $5.42B | $788.6M | +17.01% |
| Q4 2016 | 2016-12-31 | $5.34B | $792.2M | +17.42% |
| Q3 2016 | 2016-09-30 | $5.34B | $797.4M | +17.54% |
| Q2 2016 | 2016-06-30 | $4.77B | $496.3M | +11.61% |
| Q1 2016 | 2016-03-31 | $4.64B | $990.0M | +27.15% |
| Q4 2015 | 2015-12-31 | $4.55B | $939.0M | +26.02% |
| Q3 2015 | 2015-09-30 | $4.55B | $1.07B | +30.71% |
| Q2 2015 | 2015-06-30 | $4.28B | $1.10B | +34.67% |
| Q1 2015 | 2015-03-31 | $3.65B | $547.2M | +17.66% |
| Q4 2014 | 2014-12-31 | $3.61B | $599.5M | +19.93% |
| Q3 2014 | 2014-09-30 | $3.48B | $498.4M | +16.72% |
| Q2 2014 | 2014-06-30 | $3.17B | $285.1M | +9.87% |
| Q1 2014 | 2014-03-31 | $3.10B | $306.5M | +10.97% |
| Q4 2013 | 2013-12-31 | $3.01B | $258.4M | +9.39% |
| Q3 2013 | 2013-09-30 | $2.98B | $446.9M | +17.64% |
| Q2 2013 | 2013-06-30 | $2.89B | $542.4M | +23.11% |
| Q1 2013 | 2013-03-31 | $2.79B | $467.6M | +20.11% |
| Q4 2012 | 2012-12-31 | $2.75B | $477.7M | +21.02% |
| Q3 2012 | 2012-09-30 | $2.53B | $353.2M | +16.20% |
| Q2 2012 | 2012-06-30 | $2.35B | $274.2M | +13.23% |
| Q1 2012 | 2012-03-31 | $2.33B | $259.2M | +12.55% |
| Q4 2011 | 2011-12-31 | $2.27B | $235.0M | +11.53% |
| Q3 2011 | 2011-09-30 | $2.18B | $378.8M | +21.03% |
| Q2 2011 | 2011-06-30 | $2.07B | $313.0M | +17.79% |
| Q1 2011 | 2011-03-31 | $2.07B | — | — |
| Q4 2010 | 2010-12-31 | $2.04B | $348.3M | +20.62% |
| Q3 2010 | 2010-09-30 | $1.80B | — | — |
| Q2 2010 | 2010-06-30 | $1.76B | — | — |
| Q4 2009 | 2009-12-31 | $1.69B | — | — |
Pediatrix Medical Group total assets trends
Over the last five fiscal years, Pediatrix Medical Group's total assets decreased from $3.35B to $2.25B, a change of −$1.10B. The latest reported quarter, Q2 2026, shows $2.13B.
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Pediatrix Medical Group source filings ↗